MedicarePartD.guide

A non-government resource built from CMS public data

Hepatitis C drugs on every 2026 Hawaii Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 8 stand-alone Part D plans in Hawaii cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Hepatitis C drugs by 2026 Hawaii Part D plan
DrugAARP Medicare Rx Saver from UHC$0.00/moS5921-381Humana Basic Rx Plan$0.40/moS5884-115SilverScript Choice$14.70/moS5601-066Wellcare Value Script$21.60/moS4802-164Wellcare Classic$21.70/moS4802-095Humana Value Rx Plan$51.60/moS5884-212Humana Premier Rx Plan$90.20/moS5884-179AARP Medicare Rx Preferred from UHC$139.20/moS5921-414
Epclusasofosbuvir and velpatasvirNot coveredTier 5PA25%QL 28/28dTier 5PA25%Not coveredNot coveredTier 5PA26%QL 28/28dTier 5PA33%QL 28/28dNot covered
sofosbuvir-velpatasvirgeneric EpclusaTier 5PA25%QL 28/28dNot coveredNot coveredTier 5PA25%QL 28/28dTier 5PA25%QL 28/28dNot coveredNot coveredTier 5PA31%QL 28/28d
Mavyretglecaprevir and pibrentasvirTier 5PA25%QL 140/28dNot coveredTier 5PA25%Not coveredNot coveredNot coveredNot coveredTier 5PA31%QL 140/28d
Harvoniledipasvir and sofosbuvirNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
ledipasvir-sofosbuvirgeneric HarvoniNot coveredNot coveredNot coveredTier 5PA25%QL 28/28dTier 5PA25%QL 28/28dNot coveredNot coveredNot covered
VosevisofosbuvirTier 5PA25%QL 28/28dTier 5PA25%QL 28/28dTier 5PA25%QL 28/28dNot coveredNot coveredTier 5PA26%QL 28/28dTier 5PA33%QL 28/28dTier 5PA31%QL 28/28d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.